Supernus Pharmaceuticals | SUPN - Lngresos Netos





Lngresos Netos Cambio Fecha
Abbott USD 1.78B 132M 2025-12
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Aurora Cannabis CAD -51.47M 36.26M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Canopy Growth CAD -1.64M 39.89M 2025-09
Cara Therapeutics USD -4.91M 2.77M 2025-03
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Novo Nordisk DKK 26.89B 388M 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
United Therapeutics USD 364.3M 25.6M 2025-12
Xeris Pharmaceuticals USD 621K 2.55M 2025-09